In that regard, it is noteworthy that lipocalin 2, a novel adipokine elevated in obesity subjects [74], has been shown to promote obesity-associated PDAC by stimulating the pro-inflammatory response in the TME [75]. The gene discussed is LCN2; the disease is obesity due to melanocortin 4 receptor deficiency.